These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9724277)

  • 1. Human neuropeptide Y potentiates alpha1-adrenergic blood pressure responses in vivo.
    Schuerch LV; Linder LM; Grouzmann E; Haefeli WE
    Am J Physiol; 1998 Sep; 275(3):H760-6. PubMed ID: 9724277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconstrictor doses of neuropeptide Y potentiate alpha 1-adrenergic venoconstriction in vivo.
    Linder L; Lautenschlager BM; Haefeli WE
    Hypertension; 1996 Sep; 28(3):483-7. PubMed ID: 8794837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients.
    Johansson BL; Pernow J
    Acta Physiol Scand; 1999 Jan; 165(1):39-44. PubMed ID: 10072095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased responsiveness of vascular postjunctional alpha1-, alpha2-adrenoceptors and neuropeptide Y1 receptors in rats with heart failure.
    Feng Q; Sun X; Lu X; Edvinsson L; Hedner T
    Acta Physiol Scand; 1999 Aug; 166(4):285-91. PubMed ID: 10468665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension.
    Gadegbeku CA; Shrayyef MZ; Taylor TP; Egan BM
    J Hypertens; 2006 Jul; 24(7):1383-9. PubMed ID: 16794488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing and leg postjunctional alpha-adrenergic vasoconstrictor responsiveness in healthy men.
    Smith EG; Voyles WF; Kirby BS; Markwald RR; Dinenno FA
    J Physiol; 2007 Jul; 582(Pt 1):63-71. PubMed ID: 17463044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variation of alpha 1-adrenoceptor-mediated pressor response to phenylephrine in man.
    Tham TC; Guy S; Riddell JG; Shanks RG; Harron DW
    J Pharm Pharmacol; 1996 May; 48(5):526-8. PubMed ID: 8799880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-adrenergic vascular responsiveness during postexercise hypotension in humans.
    Halliwill JR; Dinenno FA; Dietz NM
    J Physiol; 2003 Jul; 550(Pt 1):279-86. PubMed ID: 12766237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1997 Jul; 44(1):61-8. PubMed ID: 9241098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity.
    Haastrup AT; Stepniakowski KT; Goodfriend TL; Egan BM
    Hypertension; 1998 Oct; 32(4):693-8. PubMed ID: 9774365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Receptor agonist activity of phenylephrine in the human forearm.
    Torp KD; Tschakovsky ME; Halliwill JR; Minson CT; Joyner MJ
    J Appl Physiol (1985); 2001 May; 90(5):1855-9. PubMed ID: 11299277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forearm vascular alpha 1-adrenergic blockade by verapamil.
    Abernethy DR; Winterbottom LM
    Clin Pharmacol Ther; 1990 Jun; 47(6):755-9. PubMed ID: 2162750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forearm vascular responsiveness to alpha 1- and alpha 2-adrenoceptor stimulation in patients with congestive heart failure.
    Indolfi C; Maione A; Volpe M; Rapacciuolo A; Esposito G; Ceravolo R; Rendina V; Condorelli M; Chiariello M
    Circulation; 1994 Jul; 90(1):17-22. PubMed ID: 7913001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system.
    Schmidt BM; Georgens AC; Martin N; Tillmann HC; Feuring M; Christ M; Wehling M
    J Clin Endocrinol Metab; 2001 Feb; 86(2):761-7. PubMed ID: 11158043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin on vasoconstrictor responses to alpha agonist and tilting.
    Yamamoto M; Asayama K; Kanai M; Sugimoto T; Yagi S; Takata S; Ikeda T; Hattori N
    Angiology; 1990 May; 41(5):394-400. PubMed ID: 1972612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors contributing to blood pressure elevation during norepinephrine and phenylephrine infusions in dogs.
    Stokland O; Thorvaldson J; Ilebekk A; Kiil F
    Acta Physiol Scand; 1983 Apr; 117(4):481-9. PubMed ID: 6136153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
    Woodman OL; Vatner SF
    J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of alpha- and beta-adrenoceptor responses by elevations in vascular tone in pulmonary circulation.
    Hyman AL; Kadowitz PJ
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H1109-16. PubMed ID: 2872820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the initial arterial tone on the pressure responses to phenylephrine.
    Osadtchy LI; Balueva TV; Sergeev IV
    Acta Physiol Hung; 2000; 87(1):77-86. PubMed ID: 11032051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.